Industry benchmark · SIC 72110
Research and experimental development on biotechnology
6,106 active companies are registered under this code; 52 publish a P&L we can benchmark.
Benchmarks
- Median revenue
- £8.1m
- Median profit
- −£8k
- Profitable
- 44%
- Median staff
- 50
- Median margin
- −0.7%
- Top-quartile margin
- 7.7%
- Median gross margin
- 53.9%
- Median profit / staff
- −£5.7k
Median
−0.7%
Top quartile (p75)
7.7%
Median revenue growth: ▲14.5%
Ranked by profit
Top research and experimental development on biotechnology businesses
| # | Company | Revenue | Profit | Margin | Staff |
|---|---|---|---|---|---|
| 1 | Astex Therapeutics Limited Cambridge · Research and experimental development on biotechnology Operating leverage | £404m | £283m | 70.2% | 183 |
| 2 | Amphista Therapeutics Limited Cambridge · Research and experimental development on biotechnology IndependentDoing more with less | £33.9m | £19.8m | 58.5% | 56 |
| 3 | Charles River U.K. Limited Kent · Research and experimental development on biotechnology | £22.2m | £18.8m | 84.9% | 129 |
| 4 | Qiagen Manchester Limited Manchester · Research and experimental development on biotechnology Operating leverageDoing more with less | £53.7m | £11.8m | 21.9% | 239 |
| 5 | Alchemab Therapeutics Ltd London · Research and experimental development on biotechnology Independent | £30m | £8.3m | 27.7% | 55 |
| 6 | Ligand UK Development Limited London · Research and experimental development on biotechnology | £8.7m | £6m | 68.9% | — |
| 7 | Sitryx Therapeutics Limited Oxford · Research and experimental development on biotechnology Independent | £23.3m | £4.7m | 20% | — |
| 8 | Dna Legal Limited Frome · Research and experimental development on biotechnology | £12.5m | £3.2m | 25.5% | 55 |
| 9 | Theradex (Europe) Limited Redhill · Research and experimental development on biotechnology IndependentCapital-light+2 | £15.2m | £3.1m | 20.3% | 43 |
| 10 | Novogene (UK) Company Limited Cambridge · Research and experimental development on biotechnology Capital-lightOperating leverage+2 | £38.2m | £2.8m | 7.3% | 68 |
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.